HeraMED Limited (FRA:1I4)
0.0200
-0.0025 (-11.11%)
At close: Jan 30, 2026
HeraMED Market Cap
HeraMED has a market cap or net worth of €26.4 million as of January 30, 2026. Its market cap has increased by 163.23% in one year.
Market Cap
26.40M
Enterprise Value
25.84M
Revenue
180.28K
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.02
Market Cap Chart
Since December 12, 2018, HeraMED's market cap has increased from 10.02M to 26.40M, an increase of 163.55%. That is a compound annual growth rate of 14.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 26.40M | 23.76% |
| Dec 31, 2025 | 21.33M | 103.79% |
| Dec 31, 2024 | 10.47M | 120.14% |
| Dec 29, 2023 | 4.75M | -75.35% |
| Dec 30, 2022 | 19.29M | -33.21% |
| Dec 31, 2021 | 28.88M | 177.48% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 12, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BREMER LAGERHAUS-GESELLSCHAFT -Aktiengesellschaft von 1877- | 36.86M |
| OTRS AG | 36.22M |
| edding AG | 35.48M |
| Readcrest Capital AG | 32.13M |
| Weng Fine Art AG | 29.35M |
| Biomark Diagnostics | 29.00M |
| Rubean AG | 27.29M |
| Hyrican Informationssysteme Aktiengesellschaft | 24.25M |